| Ident. | Authors (with country if any) | Title |
|---|
| 000302 (2021) |
Roberta Gagliardini [Italie] ; Alessandro Cozzi-Lepri [Royaume-Uni] ; Andrea Mariano [Italie] ; Fabrizio Taglietti [Italie] ; Alessandra Vergori [Italie] ; Amina Abdeddaim [Italie] ; Francesco Di Gennaro [Italie] ; Valentina Mazzotta [Italie] ; Alessandra Amendola [Italie] ; Giampiero D'Offizi [Italie] ; Fabrizio Palmieri [Italie] ; Luisa Marchioni [Italie] ; Pierluca Piselli [Italie] ; Chiara Agrati [Italie] ; Emanuele Nicastri [Italie] ; Maria Rosaria Capobianchi [Italie] ; Nicola Petrosillo [Italie] ; Giuseppe Ippolito [Italie] ; Francesco Vaia [Italie] ; Enrico Girardi [Italie] ; Andrea Antinori [Italie] | No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison. |
| 000314 (2021) |
Kauê Francisco Corrêa Souza E Souza [Brésil] ; Bianca Portugal Tavares Moraes [Brésil] ; Izabel Christina Nunes De Palmer Paixão [Brésil] ; Patrícia Burth [Brésil] ; Adriana Ribeiro Silva [Brésil] ; Cassiano Felippe Gonçalves-De-Albuquerque [Brésil] | Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection. |
| 000335 (2021) |
Charlotte Kern [Suisse] ; Verena Schöning [Suisse] ; Carlos Chaccour [Espagne, Tanzanie] ; Felix Hammann [Suisse] | Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing. |
| 000454 (2021) |
Hang Xu [République populaire de Chine] ; Xiang Yang Zhang [République populaire de Chine] ; Wei Wen Wang [République populaire de Chine] ; Jiesi Wang [République populaire de Chine] | Hydroxychloroquine Increased Anxiety-Like Behaviors and Disrupted the Expression of Some Related Genes in the Mouse Brain. |
| 000505 (2021) |
Zeinab Abdelrahman [République populaire de Chine] ; Qian Liu [République populaire de Chine] ; Shanmei Jiang [République populaire de Chine] ; Mengyuan Li [République populaire de Chine] ; Qingrong Sun [République populaire de Chine] ; Yue Zhang [République populaire de Chine] ; Xiaosheng Wang [République populaire de Chine] | Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis. |
| 000596 (2021) |
Franco De Crescenzo [Royaume-Uni, Italie] ; Laura Amato [Italie] ; Fabio Cruciani [Italie] ; Luke P. Moynihan [Royaume-Uni] ; Gian Loreto D'Al [Italie] ; Simona Vecchi [Italie] ; Rosella Saulle [Italie] ; Zuzana Mitrova [Italie] ; Valeria Di Franco [Italie] ; Antonio Addis [Italie] ; Marina Davoli [Italie] | Comparative Effectiveness of Pharmacological Interventions for Covid-19: A Systematic Review and Network Meta-Analysis. |
| 000744 (2021) |
Omkar Indari [Inde] ; Shweta Jakhmola [Inde] ; Elangovan Manivannan [Inde] ; Hem Chandra Jha [Inde] | An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come? |
| 000786 (2021) |
Muhammad Harris Shoaib [Pakistan] ; Farrukh Rafiq Ahmed [Pakistan] ; Muhammad Sikandar [Pakistan] ; Rabia Ismail Yousuf [Pakistan] ; Muhammad Talha Saleem [Pakistan] | A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management. |
| 000B54 (2020) |
Tyler C. Beck [États-Unis] ; Kyle R. Beck [États-Unis] ; Calvin B. Holloway [États-Unis] ; Richard A. Hemings [États-Unis] ; Thomas A. Dix [États-Unis] ; Russell A. Norris [États-Unis] | The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine. |
| 000B80 (2020) |
Hongwei Peng [République populaire de Chine] ; Zhangren Chen [République populaire de Chine] ; Yunyun Wang [République populaire de Chine] ; Simei Ren [République populaire de Chine] ; Tiantian Xu [République populaire de Chine] ; Xin Lai [République populaire de Chine] ; Jinhua Wen [République populaire de Chine] ; Mengjun Zhao [République populaire de Chine] ; Chuanfei Zeng [République populaire de Chine] ; Lijuan Du [République populaire de Chine] ; Yanmei Zhang [République populaire de Chine] ; Li Cao [République populaire de Chine] ; Jinfang Hu [République populaire de Chine] ; Xiaohua Wei [République populaire de Chine] ; Tao Hong [République populaire de Chine] | Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19. |
| 000C66 (2020) |
Simona Iacob [Roumanie] ; Diana Gabriela Iacob [Roumanie] | SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus. |
| 000D34 (2020) |
Yan Chen [République populaire de Chine] ; Taipeng Shen [République populaire de Chine] ; Lijun Zhong [République populaire de Chine] ; Zhixi Liu [République populaire de Chine] ; Xinwei Dong [République populaire de Chine] ; Tingwenli Huang [République populaire de Chine] ; Qiuju Wang [République populaire de Chine] ; Hongtao Xiao [République populaire de Chine] | Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use. |
| 000D70 (2020) |
Israel Abebrese Sefah [Ghana] ; Olayinka O. Ogunleye [Nigeria] ; Darius Obeng Essah [Ghana] ; Sylvia A. Opanga [Kenya] ; Nadia Butt [Kenya] ; Annie Wamaitha [Kenya] ; Anastasia Nkatha Guantai [Kenya] ; Ibrahim Chikowe [Malawi] ; Felix Khuluza [Malawi] ; Dan Kibuule [Namibie] ; Lahya Nambahu [Namibie] ; Abdullahi Rabiu Abubakar [Nigeria] ; Ibrahim Haruna Sani [Nigeria] ; Zikria Saleem [Pakistan] ; Aubrey C. Kalungia [Zambie] ; Thuy Nguyen Thi Phuong [Viêt Nam] ; Mainul Haque [Malaisie] ; Salequl Islam [Bangladesh] ; Santosh Kumar [Inde] ; Jacqueline Sneddon [Royaume-Uni] ; Joshua Wamboga [Ouganda] ; Janney Wale [Australie] ; Nenad Miljkovi [Serbie] ; Amanj Kurdi [Royaume-Uni, Iraq] ; Antony P. Martin [Royaume-Uni] ; Brian Godman [Royaume-Uni, Afrique du Sud, Malaisie, Suède] | Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. |
| 000E82 (2020) |
Arghadip Samaddar [Inde] ; Malika Grover [Inde] ; Vijaya Lakshmi Nag [Inde] | Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena. |
| 000E88 (2020) |
Carmen Abate [Italie] ; Mauro Niso [Italie] ; Francesca Serena Abatematteo [Italie] ; Marialessandra Contino [Italie] ; Nicola Antonio Colabufo [Italie] ; Francesco Berardi [Italie] | PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti-SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships. |
| 000F70 (2020) |
Zhihong Zuo [République populaire de Chine] ; Ting Wu [République populaire de Chine] ; Liangyu Pan [République populaire de Chine] ; Chenzhe Zuo [République populaire de Chine] ; Yingchuo Hu [République populaire de Chine] ; Xuan Luo [République populaire de Chine] ; Liping Jiang [République populaire de Chine] ; Zanxian Xia [République populaire de Chine] ; Xiaojuan Xiao [République populaire de Chine] ; Jing Liu [République populaire de Chine] ; Mao Ye [République populaire de Chine] ; Meichun Deng [République populaire de Chine] | Modalities and Mechanisms of Treatment for Coronavirus Disease 2019. |
| 001065 (2020) |
Elena Ramírez [Espagne] ; Mikel Urroz [Espagne] ; Amelia Rodríguez [Espagne] ; Miguel González-Mu Oz [Espagne] ; Alberto Martín-Vega [Espagne] ; Yuri Villán [Espagne] ; Enrique Seco [Espagne] ; Jaime Monserrat [Espagne] ; Jesús Frías [Espagne] ; Antonio J. Carcas [Espagne] ; Alberto M. Borobia [Espagne] | Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data. |
| 001179 (2020) |
Nour K. Younis [Liban] ; Rana O. Zareef [Liban] ; Sally N. Al Hassan [Liban] ; Fadi Bitar [Liban] ; Ali H. Eid [Qatar, Liban] ; Mariam Arabi [Liban] | Hydroxychloroquine in COVID-19 Patients: Pros and Cons. |
| 001202 (2020) |
Mudit Agarwal [Inde] ; Piyush Ranjan [Inde] ; Upendra Baitha [Inde] ; Ankit Mittal [Inde] | Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review. |
| 001205 (2020) |
Manuela Monti [Italie] ; Bernadette Vertogen [Italie] ; Carla Masini [Italie] ; Caterina Donati [Italie] ; Claudia Lilli [Italie] ; Chiara Zingaretti [Italie] ; Gerardo Musuraca [Italie] ; Ugo De Giorgi [Italie] ; Claudio Cerchione [Italie] ; Alberto Farolfi [Italie] ; Pietro Cortesi [Italie] ; Pierluigi Viale [Italie] ; Giovanni Martinelli [Italie] ; Oriana Nanni [Italie] | Hydroxychloroquine as Prophylaxis for COVID-19: A Review. |
| 001369 (2020) |
Vincenzo Russo [Italie] ; Andreina Carbone [Italie] ; Filiberto Fausto Mottola [Italie] ; Rosa Mocerino [Italie] ; Raffaele Verde [Italie] ; Emilio Attena [Italie] ; Nicoletta Verde [Italie] ; Pierpaolo Di Micco [Italie] ; Luigi Nunziata [Italie] ; Francesco Santelli [Italie] ; Gerardo Nigro [Italie] ; Sergio Severino [Italie] | Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients. |
